Needham Reiterates Buy Rating on Absci Corporation (ABSI)

Market Context

Absci Corporation operates in the Healthcare sector. The stock currently trades at $9.18 with a market capitalization of $412.0M. The stock has gained 208.6% over the past 52 weeks.

Analyst coverage from Needham provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Absci Corporation.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Absci Corporation

Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Aug 12, 2026	Needham	Buy	N/A
Aug 12, 2026	BTIG	Buy	N/A
Jul 02, 2026	Truist Securities	Buy	N/A
Jun 25, 2026	HC Wainwright & Co.	Buy	N/A
Jun 24, 2026	Needham	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View ABSI Stock Page